Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sanjay Popat

Showing results (61-70 of 272) with videos related to

Pageof 28
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 25, 2021
Grading in Lung Adenocarcinoma: Another New NormalAndrew G Nicholson, Andre L Moreira, Mari Mino-Kenudson, et al.
Lung Cancer (Amsterdam, Netherlands)|December 4, 2009
The combination of Young's syndrome and small cell lung cancer-A spiky connection?Martin Forster, Deborah Enting, Andrew G Nicholson, et al.
European Journal of Cancer (Oxford, England : 1990)|March 11, 2022
Inadequacy of PCR genotyping in advanced non-small cell lung cancer: EGFR L747_A755delinsSS exon 19 deletion is not detected by the real-time PCR Idylla™ EGFR mutation test but is detected by ctDNA next generation sequencing and responds to osimertinibHazel O'Sullivan, Paolo D d'Arienzo, Nadia Yousaf, et al.
The Lancet. Oncology|January 1, 2022
Assessment of tumour-agnostic therapies in basket trialsSanjay Popat, Sreeram V Ramagopalan, Joshua Ray, et al.
Plos One|October 25, 2011
Excision repair cross-complementation group 1 (ERCC1) status and lung cancer outcomes: a meta-analysis of published studies and recommendationsRichard A Hubner, Richard D Riley, Lucinda J Billingham, et al.
British Journal of Haematology|February 6, 2020
Durable response of multiple myeloma and non-small cell lung cancer with simultaneous, biologically targeted treatmentMartin F Kaiser, James Croft, Paras Shah, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 29, 2020
Lorlatinib Salvages Central Nervous System-Only Relapse on Entrectinib in ROS1-Positive NSCLCNiamh Coleman, Nadia Yousaf, Hendrik-Tobias Arkenau, et al.
European Journal of Cancer (Oxford, England : 1990)|August 10, 2022
Response to letter entitled: Re: 'Inadequacy of PCR genotyping in advanced non-small cell lung cancer: EGFR L747_A755delinsSS exon 19 deletion is not detected by the real-time PCR Idylla<sup>TM</sup> EGFR mutation test but is detected by ctDNA NGS and responds to osimertinib': Not looking backHazel O'Sullivan, Paolo D d'Arienzo, Nadia Yousaf, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 26, 2016
Brain Metastases from NSCLC: Radiation Therapy in the Era of Targeted TherapiesJonathan Khalifa, Arya Amini, Sanjay Popat, et al.
Clinical Lung Cancer|September 15, 2010
Supersensitive mutation: two case reports of non-small-cell lung cancer treated with epidermal growth factor receptor tyrosine kinase inhibitorsJames S Myerson, Syed A Iqbal, Mary E R O'Brien, et al.
Pageof 28

Showing results (61-70 of 272) with videos related to

Sort By:
Pageof 28
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 25, 2021
Grading in Lung Adenocarcinoma: Another New NormalAndrew G Nicholson, Andre L Moreira, Mari Mino-Kenudson, et al.
Lung Cancer (Amsterdam, Netherlands)|December 4, 2009
The combination of Young's syndrome and small cell lung cancer-A spiky connection?Martin Forster, Deborah Enting, Andrew G Nicholson, et al.
European Journal of Cancer (Oxford, England : 1990)|March 11, 2022
Inadequacy of PCR genotyping in advanced non-small cell lung cancer: EGFR L747_A755delinsSS exon 19 deletion is not detected by the real-time PCR Idylla™ EGFR mutation test but is detected by ctDNA next generation sequencing and responds to osimertinibHazel O'Sullivan, Paolo D d'Arienzo, Nadia Yousaf, et al.
The Lancet. Oncology|January 1, 2022
Assessment of tumour-agnostic therapies in basket trialsSanjay Popat, Sreeram V Ramagopalan, Joshua Ray, et al.
Plos One|October 25, 2011
Excision repair cross-complementation group 1 (ERCC1) status and lung cancer outcomes: a meta-analysis of published studies and recommendationsRichard A Hubner, Richard D Riley, Lucinda J Billingham, et al.
British Journal of Haematology|February 6, 2020
Durable response of multiple myeloma and non-small cell lung cancer with simultaneous, biologically targeted treatmentMartin F Kaiser, James Croft, Paras Shah, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 29, 2020
Lorlatinib Salvages Central Nervous System-Only Relapse on Entrectinib in ROS1-Positive NSCLCNiamh Coleman, Nadia Yousaf, Hendrik-Tobias Arkenau, et al.
European Journal of Cancer (Oxford, England : 1990)|August 10, 2022
Response to letter entitled: Re: 'Inadequacy of PCR genotyping in advanced non-small cell lung cancer: EGFR L747_A755delinsSS exon 19 deletion is not detected by the real-time PCR Idylla<sup>TM</sup> EGFR mutation test but is detected by ctDNA NGS and responds to osimertinib': Not looking backHazel O'Sullivan, Paolo D d'Arienzo, Nadia Yousaf, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 26, 2016
Brain Metastases from NSCLC: Radiation Therapy in the Era of Targeted TherapiesJonathan Khalifa, Arya Amini, Sanjay Popat, et al.
Clinical Lung Cancer|September 15, 2010
Supersensitive mutation: two case reports of non-small-cell lung cancer treated with epidermal growth factor receptor tyrosine kinase inhibitorsJames S Myerson, Syed A Iqbal, Mary E R O'Brien, et al.
Pageof 28